bioAffinity Technologies
BIAF
14 hedge funds and large institutions have $104K invested in bioAffinity Technologies in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 6 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
0.97% less ownership
Funds ownership: 3.3% → 2.32% (-0.97%)
13% less funds holding
Funds holding: 16 → 14 (-2)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
43% less capital inflows, than outflows
Capital inflows: $38.4K | Capital outflows: $67.5K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Allworth Financial
Folsom,
California
|
+$20.4K |
| 2 |
StoneX Group
New York
|
+$5.83K |
| 3 |
IFP Advisors
Tampa,
Florida
|
+$3.94K |
| 4 |
Sprott Inc
Toronto,
Ontario, Canada
|
+$3.77K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.57K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$52K |
| 2 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$5.87K |
| 3 |
Van Hulzen Asset Management
El Dorado Hills,
California
|
-$4.16K |
| 4 |
HRT Financial
New York
|
-$4K |
| 5 |
Barclays
London,
United Kingdom
|
-$827 |
BIAF Hedge Fund Activity: Q2 2025 in Review
14 of the 7,629 institutional investors tracked by Wall St. Rank reported a position in bioAffinity Technologies (BIAF) for Q2 2025, worth a combined $104K — down 22% from $133K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of BIAF and 5 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 3 added.
The largest buyer was Allworth Financial, opening a new position worth an estimated $20.4K. The largest seller was Vanguard Group, cutting an estimated $52K.
- 14 institutional investors held bioAffinity Technologies (BIAF) as of Q2 2025, down from 16 in Q1 2025.
- Funds reported $104K of bioAffinity Technologies stock for Q2 2025, down 22% quarter-over-quarter.
- 5 funds opened new bioAffinity Technologies positions in Q2 2025 and 6 closed out, a net change of -1 holder.
- The largest bioAffinity Technologies buyer in Q2 2025 was Allworth Financial, an estimated $20.4K added.
- The largest bioAffinity Technologies seller in Q2 2025 was Vanguard Group, an estimated $52K sold.
Based on aggregated 13F filings for Q2 2025.